SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

League of Degens 

DEGEN is capturing significant investor attention as the project transitions from a Farcaster tipping token into a brand-focused SocialFi ecosystem, driven by active token buyback and burn programs. Community discourse is currently polarized between optimistic long-term holders tracking upcoming app launches and skeptical traders debating the token's recent price volatility.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph is capturing significant attention as investors speculate on its role in the expanding AI and Web3 infrastructure narrative, with community members closely tracking technical upgrades like the Horizon Mainnet and increased cross-chain data integration. Despite mixed sentiment regarding historical performance and token dilution, many are accumulating positions in anticipation of a potential breakout driven by its essential indexing utility.

RoboStrategy, Inc. is a non-diversified, closed-end management investment company, which engages in investing in equity and equity-linked securities of private and public companies operating in the fields of robotics and embodied artificial intelligence. The company was founded on May 23, 2025 and is headquartered in San Juan, Puerto Rico.

RoboStrategy Inc

RoboStrategy, Inc.

RoboStrategy, Inc. is trending as traders speculate on its potential to mirror the rapid valuation growth of past high-profile IPOs and closed-end funds focused on emerging technology. The community is actively debating the fund's heavy exposure to private robotics companies and physical AI, while closely monitoring volatility and potential short-squeeze setups following recent price swings.

The Travelers Cos., Inc. is a holding company, which engages in the provision of commercial and personal property and casualty insurance products and services. It operates through the following business segments: Business Insurance, Bond and Specialty Insurance, and Personal Insurance. The Business Insurance segment offers an array of property and casualty insurance, and insurance related services to its customers primarily in the U.S., as well as in Canada, the United Kingdom, the Republic of Ireland and throughout other parts of the world as a corporate member of Lloyd's. The Bond and Specialty Insurance segment includes surety, fidelity, management of liability, professional liability, and other property and casualty coverage and related risk management services. The Personal Insurance segment is involved in a range of property and casualty insurance products and services covering individuals' personal risks, primarily in the U.S. and Canada. The company was founded in 1853 and is headquartered in New York, NY.

Travelers Companies Inc.

Travelers Companies is currently drawing significant attention from the investment community due to its strategic acquisition of Corvus Insurance, aimed at bolstering its cyber insurance capabilities. Investors are actively discussing the company's solid underwriting fundamentals and strong financial performance, which continue to drive momentum despite broader challenges within the property and casualty insurance sector.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Surrozen is trending as investors monitor potential buyout preparations and institutional accumulation, with community discourse centered on the company's WNT-pathway expertise and the value of its ophthalmology pipeline following recent sector acquisitions. Discussions are particularly focused on the strategic timing of pipeline updates and clinical trial milestones relative to the company's future corporate direction.

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

vTv Therapeutics Inc - Ordinary Shares - Class A

vTv Therapeutics is experiencing intense community debate following a clinical hold on its lead type 1 diabetes candidate, with investors split between long-term bullish sentiment over potential breakthrough therapy status and skepticism regarding management's communication and the extended trial delay. The stock remains highly volatile as market participants closely monitor for any regulatory updates that could signal a path forward for the cadisegliatin program.

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is trending as investors debate whether the company's aggressive acquisition strategy and diversification into alternative asset management create a compelling undervaluation opportunity or excessive risk, particularly as the market navigates the potential impact of interest rate shifts on its mortgage servicing rights and REIT status. The community is actively discussing the stock's persistent discount to book value, speculating on future restructuring or spin-off possibilities, and weighing long-term growth potential against concerns over dilution and capital allocation.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing positive momentum following favorable late-stage cardiovascular trial data and regulatory expansions for its CAR-T therapy, Breyanzi. Investors are actively discussing the company's attractive dividend yield and the potential for its growing oncology and cardiovascular pipeline to offset revenue pressures from legacy drugs.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Investors are actively focusing on Evolution Metals & Technologies due to its role in domestic critical mineral supply chains, with the stock seeing significant volatility and volume spikes often associated with low-float dynamics. The community is closely debating the company's long-term production scaling potential versus its aggressive, news-driven price swings, with many traders drawing parallels to other recent high-volatility market plays.

Got that dog in you? - Fueled by a mantra of tokenized self-belief, doginme is representative of the community's collective efforts to embrace and embolden that dog in them. doginme stands for knowing yourself and having that unshakable drive to keep pushing forward. doginme was originally launched in February 2024 when the Farcaster founder was asked if he owned a dog, to which he replied affirmatively: "no but I got that dog in me"

doginme

DOGINME is generating significant community buzz as a Base-chain meme coin, with holders rallying around its "self-belief" narrative and cultural stickiness. Supporters are actively pointing to its low market cap and recent exchange listings as catalysts for future momentum, while discussions remain highly divided between those betting on an explosive run and skeptics dismissing the token as a scam.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
